BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 22353215)

  • 1. A low TAFI activity and insufficient activation of fibrinolysis by both plasmin and neutrophil elastase promote organ dysfunction in disseminated intravascular coagulation associated with sepsis.
    Hayakawa M; Sawamura A; Gando S; Jesmin S; Naito S; Ieko M
    Thromb Res; 2012 Dec; 130(6):906-13. PubMed ID: 22353215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
    Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
    Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activation of neutrophil elastase-mediated fibrinolysis is not sufficient to overcome the fibrinolytic shutdown of disseminated intravascular coagulation associated with systemic inflammation.
    Gando S; Hayakawa M; Sawamura A; Hoshino H; Oshiro A; Kubota N; Jesmin S
    Thromb Res; 2007; 121(1):67-73. PubMed ID: 17397908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disseminated intravascular coagulation at an early phase of trauma is associated with consumption coagulopathy and excessive fibrinolysis both by plasmin and neutrophil elastase.
    Hayakawa M; Sawamura A; Gando S; Kubota N; Uegaki S; Shimojima H; Sugano M; Ieko M
    Surgery; 2011 Feb; 149(2):221-30. PubMed ID: 20655560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma antigen levels of thrombin-activatable fibrinolysis inhibitor did not differ in patients with or without disseminated intravascular coagulation.
    Chen CC; Lee KD; Gau JP; Yu YB; You JY; Lee SC; Hsu HC; Chau WK; Ho CH
    Ann Hematol; 2005 Oct; 84(10):675-80. PubMed ID: 16007424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial changes in neutrophil-endothelial activation markers during the course of sepsis associated with disseminated intravascular coagulation.
    Gando S; Kameue T; Matsuda N; Hayakawa M; Hoshino H; Kato H
    Thromb Res; 2005; 116(2):91-100. PubMed ID: 15907522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of cross-linked fibrin by leukocyte elastase as alternative pathway for plasmin-mediated fibrinolysis in sepsis-induced disseminated intravascular coagulation.
    Madoiwa S; Tanaka H; Nagahama Y; Dokai M; Kashiwakura Y; Ishiwata A; Sakata A; Yasumoto A; Ohmori T; Mimuro J; Sakata Y
    Thromb Res; 2011 Apr; 127(4):349-55. PubMed ID: 21236472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical course and outcome of disseminated intravascular coagulation diagnosed by Japanese Association for Acute Medicine criteria. Comparison between sepsis and trauma.
    Kushimoto S; Gando S; Saitoh D; Ogura H; Mayumi T; Koseki K; Ikeda T; Ishikura H; Iba T; Ueyama M; Eguchi Y; Otomo Y; Okamoto K; Endo S; Shimazaki S;
    Thromb Haemost; 2008 Dec; 100(6):1099-105. PubMed ID: 19132236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients.
    Voves C; Wuillemin WA; Zeerleder S
    Blood Coagul Fibrinolysis; 2006 Sep; 17(6):445-51. PubMed ID: 16905947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminated intravascular coagulation (DIC) diagnosed based on the Japanese Association for Acute Medicine criteria is a dependent continuum to overt DIC in patients with sepsis.
    Gando S; Saitoh D; Ogura H; Mayumi T; Koseki K; Ikeda T; Ishikura H; Iba T; Ueyama M; Eguchi Y; Otomo Y; Okamoto K; Kushimoto S; Endo S; Shimazaki S;
    Thromb Res; 2009 Mar; 123(5):715-8. PubMed ID: 18774163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of fibrinolysis in sepsis.
    Gando S
    Semin Thromb Hemost; 2013 Jun; 39(4):392-9. PubMed ID: 23446914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated plasma levels of fibrin degradation products by granulocyte-derived elastase in patients with disseminated intravascular coagulation.
    Matsumoto T; Wada H; Nobori T; Nakatani K; Onishi K; Nishikawa M; Shiku H; Kazahaya Y; Sawai T; Koike K; Matsuda M
    Clin Appl Thromb Hemost; 2005 Oct; 11(4):391-400. PubMed ID: 16244764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation.
    Watanabe R; Wada H; Watanabe Y; Sakakura M; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Nobori T; Shiku H
    Thromb Res; 2001 Oct; 104(1):1-6. PubMed ID: 11583733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective comparison of new Japanese Association for Acute Medicine (JAAM) DIC and International Society of Thrombosis and Hemostasis (ISTH) DIC score in critically ill septic patients.
    Singh RK; Baronia AK; Sahoo JN; Sharma S; Naval R; Pandey CM; Poddar B; Azim A; Gurjar M
    Thromb Res; 2012 Apr; 129(4):e119-25. PubMed ID: 22138415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble thrombomodulin increases in patients with disseminated intravascular coagulation and in those with multiple organ dysfunction syndrome after trauma: role of neutrophil elastase.
    Gando S; Nakanishi Y; Kameue T; Nanzaki S
    J Trauma; 1995 Oct; 39(4):660-4. PubMed ID: 7473950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sepsis, thrombosis and organ dysfunction.
    Semeraro N; Ammollo CT; Semeraro F; Colucci M
    Thromb Res; 2012 Mar; 129(3):290-5. PubMed ID: 22061311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined activation of coagulation and inflammation has an important role in multiple organ dysfunction and poor outcome after severe trauma.
    Gando S; Kameue T; Matsuda N; Hayakawa M; Ishitani T; Morimoto Y; Kemmotsu O
    Thromb Haemost; 2002 Dec; 88(6):943-9. PubMed ID: 12529743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Levels of Plasminogen Activator Inhibitor-1 (PAI-1) and Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in Patients with Disseminated Intravascular Coagulation (DIC).
    Wada H; Nobori T; Watanabe R; Shiku H; Sakuragawa N
    Turk J Haematol; 2002 Jun; 19(2):235-7. PubMed ID: 27264764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low levels of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with chronic liver disease.
    Van Thiel DH; George M; Fareed J
    Thromb Haemost; 2001 Apr; 85(4):667-70. PubMed ID: 11341503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.